General Information of Drug Inactive Ingredient (DIG) (ID: E00430)

DIG Name
Potassium acetate
Synonyms
Potassium acetate; 127-08-2; ACETIC ACID, POTASSIUM SALT; Diuretic salt; Acetic acid potassium salt; potassium;acetate; KOAc; Acetic acid, potassium salt (1:1); MFCD00012458; AcOK; UNII-M911911U02; CH3CO2K; E261; CHEBI:32029; M911911U02; Potassium ethanoate; Octan draselny [Czech]; potassiumacetate; FEMA No. 2920; Acetic acid, potassium salt, 99+%, ACS reagent; Acetic acid, potassium salt, 99+%, for analysis; Potassium acetate (TN); Acetic acid, potassium salt, 97%, pure, anhydrous; EINECS 204-822-2; Acetic acid, potassium salt, 99+%, for biochemistry; Acetic acid, potassium salt, 99+%, pure, anhydrous; Potassium acetate in plastic container; Acetic acid, potassium salt, 99+%, for molecular biology; Kaliumazetat; C2H3KO2; Potassium acetate [USP:JAN]; potasium acetate; potassium acetat; potassium-acetate; MeCO2K; CH3COOK; Potassium acetate solution; DSSTox_CID_7043; EC 204-822-2; DSSTox_RID_78289; DSSTox_GSID_27043; Potassium acetate (JAN/USP); ACMC-1C281; Potassium acetate solution, 5M; CHEMBL1201058; DTXSID7027043; Potassium Acetate A.C.S. reagent; Potassium Acetate, biochemical grade; Tox21_202740; ANW-46027; s4843; AKOS003052760; AKOS015901668; CCG-266027; DB14498; POTASSIUM ACETATE ACS GRADE 1KG; Potassium acetate, 8M aqueous solution; NCGC00260288-01; AK-77277; BP-21033; CAS-127-08-2; Potassium Acetate, Molecular Biology Grade; FT-0645118; X9686; 1819-EP2269987A1; 1819-EP2269993A1; 1819-EP2270006A1; 1819-EP2270008A1; 1819-EP2272832A1; 1819-EP2274983A1; 1819-EP2275398A1; 1819-EP2275404A1; 1819-EP2275414A1; 1819-EP2275469A1; 1819-EP2277858A1; 1819-EP2277865A1; 1819-EP2277867A2; 1819-EP2280003A2; 1819-EP2281817A1; 1819-EP2284159A1; 1819-EP2286811A1; 1819-EP2287940A1; 1819-EP2292592A1; 1819-EP2292617A1; 1819-EP2295406A1; 1819-EP2295409A1; 1819-EP2298731A1; 1819-EP2298734A2; 1819-EP2298761A1; 1819-EP2298767A1; 1819-EP2298828A1; 1819-EP2299510A1; 1819-EP2301923A1; 1819-EP2301936A1; 1819-EP2301983A1; 1819-EP2302015A1; 1819-EP2305668A1; 1819-EP2305675A1; 1819-EP2305682A1; 1819-EP2305687A1; 1819-EP2305695A2; 1819-EP2305696A2; 1819-EP2305697A2; 1819-EP2305698A2; 1819-EP2305769A2; 1819-EP2305825A1; 1819-EP2308812A2; 1819-EP2308828A2; 1819-EP2308838A1; 1819-EP2308857A1; 1819-EP2308877A1; 1819-EP2308879A1; 1819-EP2308880A1; 1819-EP2311808A1; 1819-EP2311826A2; 1819-EP2311829A1; 1819-EP2311837A1; 1819-EP2311842A2; 1819-EP2314295A1; 1819-EP2314587A1; 1819-EP2316905A1; 1819-EP2316906A2; 1819-EP2371812A1; 1819-EP2372017A1; 1819-EP2374538A1; 1819-EP2374895A1; 1819-EP2380661A2; 4-Chloro-N-furfuryl-5-sulfamoylanthranlic acid; 7839-EP2295432A1; 7839-EP2295433A2; 7839-EP2301536A1; 7839-EP2301538A1; 7839-EP2301923A1; 7839-EP2305682A1; 7839-EP2308873A1; 7839-EP2308875A1; 7839-EP2308879A1; 7839-EP2311455A1; 7839-EP2311807A1; 7839-EP2311829A1; 7839-EP2311837A1; 7839-EP2311842A2; 7839-EP2316452A1; 7839-EP2316835A1; 7839-EP2316905A1; 7839-EP2316906A2; 7839-EP2380661A2; C12554; D01154; Potassium acetate, Trace metals grade 99.98%; Potassium acetate, 1M aqueous solution, pH 7.5; Q409199; J-005461; Potassium acetate, 8M aqueous solution, RNAse free; Potassium acetate, 1M aqueous solution, pH 7.5, RNAse free
DIG Function
Film/membrane-forming agent
Formula
C2H3KO2
Canonical SMILES
CC(=O)[O-].[K+]
InChI
1S/C2H4O2.K/c1-2(3)4;/h1H3,(H,3,4);/q;+1/p-1
InChIKey
SCVFZCLFOSHCOH-UHFFFAOYSA-M
Physicochemical Properties Molecular Weight 98.14 Topological Polar Surface Area 40.1
XlogP N.A. Complexity 34.6
Heavy Atom Count 5 Rotatable Bond Count 0
Hydrogen Bond Donor Count 0 Hydrogen Bond Acceptor Count 2

Full List of Drug(s) Co-administrated with This DIG

3 Approved Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Acetaminophen DMUIE76 Pain [MG30-MG3Z] Acetaminophen 325 mg capsule F00117
Echothiophate Iodide DMSNVGB Chronic glaucoma [9C61.0Z] Echothiophate Iodide 0.125% solution F23144
Olaparib DM8QB1D Ovarian cancer [2C73] Olaparib 50 mg capsule F15763
------------------